This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Blueprint Medicines Corporation. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Josh Waetzig: Innovator in Pharmaceutical Development
Introduction
Josh Waetzig is a notable inventor based in Waltham, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptors.
Latest Patents
Josh Waetzig holds 1 patent for his work on inhibitors of activin receptor-like kinase. This patent describes compounds that inhibit ALK2 and its mutants, along with pharmaceutical compositions that include these compounds and methods for their use.
Career Highlights
Josh is currently employed at Blueprint Medicines Corporation, where he continues to advance his research and development efforts in the pharmaceutical industry. His work focuses on innovative solutions that address critical health challenges.
Collaborations
Throughout his career, Josh has collaborated with talented professionals, including Kevin J. Wilson and Natasja Brooijmans, enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Josh Waetzig's contributions to pharmaceutical innovation exemplify the importance of targeted research in developing effective treatments. His work continues to influence the field and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile